Basit öğe kaydını göster

dc.contributor.authorİsaoğlu, Ünal
dc.contributor.authorYılmaz, Mehmet
dc.contributor.authorŞener, Ebru
dc.contributor.authorÇetin, Nihal
dc.contributor.authorAltuner, Durdu
dc.contributor.authorBilen, Habib
dc.contributor.authorYapca, Ömer Erkan
dc.contributor.authorDemiryılmaz, İsmail
dc.contributor.authorİsaoğlu, Neslihan
dc.contributor.authorGül, Mehmet Ali
dc.contributor.authorKumbasar, Serkan
dc.contributor.authorSüleyman, Halis
dc.date.accessioned2020-12-19T20:05:06Z
dc.date.available2020-12-19T20:05:06Z
dc.date.issued2012
dc.identifier.citationİsaoğlu, Ü., Yılmaz, M., Şener, E., Çetin, N., Altuner, D., Bilen, H., Yapca, OE. ve diğerleri. (2012). The impaired balances of oxidant/antioxidant and COX-1/COX-2 in ovarian ischemia-reperfusion injury and prevention by Nimesulide. Latin American Journal of Pharmacy, 31(10), 1481-1488.en_US
dc.identifier.issn0326-2383
dc.identifier.urihttps://hdl.handle.net/11436/3404
dc.descriptionCetin, Nihal/0000-0003-3233-8009; Gul, Mehmet Ali/0000-0002-5849-0116;en_US
dc.descriptionWOS: 000321086300017en_US
dc.description.abstractThe aims of this study were to investigate the association of ovarian I/R injury with oxidant/antioxidant and cyclooxygenase activity and to examine the effect of nimesulide in I/R injury. Rats were divided into four groups: sham group, ischemia-reperfusion group (IR), nimesulide 25 mg/kg group (NIM 25), and nimesulide 50 mg/kg group (NIM 50). the severe oxidative stress and inflammation that occurred in the ovarian tissue treated I/R were recovered by treatment of nimesulide. the histopathological findings, severe haemorrhage, oedema, vascular congestion accompanied with migration and adhesion of polimorphonuclear leukocytes in the endothelium were observed in the IR group that MDA, MPO and COX-2 levels were found high whereas GSH and COX-1 levels were found low. the severe histopathological findings in IR group were moderate in NIM-25 group whereas those were slight in NIM-50 group. This finding suggests that nimesulide prevents injury due to reperfusion following ischemia better when used with dosage 50 mg/kg.en_US
dc.language.isoengen_US
dc.publisherColegio Farmaceuticos Provincia de Buenos Airesen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntioxidanten_US
dc.subjectIschaemia-Reperfusionen_US
dc.subjectNimesulideen_US
dc.subjectRaten_US
dc.titleThe impaired balances of oxidant/antioxidant and COX-1/COX-2 in ovarian ischemia-reperfusion injury and prevention by Nimesulideen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorAltuner, Durdu
dc.identifier.volume31en_US
dc.identifier.issue10en_US
dc.identifier.startpage1481en_US
dc.identifier.endpage1488en_US
dc.relation.journalLatin American Journal of Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster